Expert Roundtable on the Evolving Role of VEGF-Targeted Agents in Treating Solid Tumors

Review the insights of multiple experts on how to optimally leverage VEGFR-targeted TKIs to manage solid tumors with this text module and accompanying downloadable slides!

Share

Program Content

Activities

VEGFR TKIs in Solid Tumors
The Evolving Role of VEGF Targeted Agents in Treating Solid Tumors
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2019

Expires: November 13, 2020

Slides: VEGFR TKIs in Solid Tumors
The Evolving Role of VEGF Targeted Agents in Treating Solid Tumors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2019

Expires: November 13, 2020

Faculty

cover img faculity

Tanios Bekaii-Saab, MD

Professor of Medicine
Mayo Clinic College of Medicine and Science
Leader
Gastrointestinal Cancer Program
Mayo Clinic Cancer Center
Phoenix, Arizona

cover img faculity

Richard S. Finn, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma